The efficacy and safety of bevacizumab beyond first progression in patients treated with first-line mFOLFOX6 followed by second-line FOLFIRI in advanced colorectal cancer: a multicenter, single-arm, phase II trial (CCOG-0801)

PURPOSE: The aim of this study was to evaluate the efficacy and safety of the planned continuation of bevacizumab beyond first progression (BBP) in Japanese patients with metastatic colorectal cancer (mCRC). METHODS: Previously untreated patients with assessable disease were treated with mFOLFOX6 pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Goro, Uehara, Keisuke, Ishigure, Kiyoshi, Yokoyama, Hiroyuki, Ishiyama, Akiharu, Eguchi, Takehiko, Tsuboi, Kenji, Ohashi, Norifumi, Fujii, Tsutomu, Sugimoto, Hiroyuki, Koike, Masahiko, Fujiwara, Michitaka, Ando, Yuich, Kodera, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456942/
https://www.ncbi.nlm.nih.gov/pubmed/22886005
http://dx.doi.org/10.1007/s00280-012-1948-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3456942/
https://www.ncbi.nlm.nih.gov/pubmed/22886005
http://dx.doi.org/10.1007/s00280-012-1948-1

Ejemplares similares